Drug lookup | Fillwise

DROSPIRENONE

All products: general benefit

Other products in the same Health Canada class (G03A, G03AC) — coverage varies; not interchangeable

Medroxyprogesterone (Depo-Provera): general benefit, Not a benefit, Listing status unconfirmed
Norethindrone (Micronor): general benefit, Not a benefit
Desogestrel + ethinyl estradiol (Marvelon 21): general benefit
Drospirenone + ethinyl estradiol (Yasmin 21): general benefit
Ethinyl estradiol + levonorgestrel (Alesse 21): general benefit, Not a benefit
Ethinyl estradiol + norethindrone (Brevicon): general benefit

3 more in the class list below

Slynd · DIN 02522802 · 4mg · tablet-28 tablet Pk

General benefitMarketed · checked 2026-09-19

StatusGeneral benefit

Write on scriptno code needed

Patient paysPatient pays: program not supplied; amount cannot be determined.

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

No interchangeable product listed in the Ontario extract

Slynd · DIN 02522802 Manufacturer: Duchesnay Inc.; listing date 2024-11-29 Health Canada: Marketed since 2022-04-20 · brand SLYND · ATC G03AC10 DROSPIRENONE · form Tablet · route Oral · ingredients DROSPIRENONE 4 MG · company Duchesnay inc · schedule Prescription

Check this DIN again · Health Canada product record

Slynd: Formulary list price $12.6600/unit (unit not stated in source; not the patient's cost)

Ministry pays: $12.6600 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101192 · Verify on the e-Formulary ↗ (DIN 02522802)

Source record

DIN 02522802: Slynd Raw flags: sec3=Y Item: 683200119; group id 795; item number 1935; lccId None; manufacturer id DUI Source form: Tab-28 Tab Pk; strength: 4mg Recorded listing: General benefit Source prices (unrounded): $12.6600; ministry $12.6600 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02522802 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101192

Shortage status: not checked (no credentials)

Other drugs in the same formulary class (68:32 Progestogens and Oral Contraceptives) and how they are covered

Matched class: 68:32 Progestogens and Oral Contraceptives

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: DESOGESTREL & ETHINYL ESTRADIOL, DROSPIRENONE & ETHINYL ESTRADIOL, ETHINYL ESTRADIOL & NORETHINDRONE, ETHINYL ESTRADIOL & NORETHINDRONE ACETATE, LEVONORGESTREL Some products covered without a code (check the product listing): ETHINYL ESTRADIOL & LEVONORGESTREL, MEDROXYPROGESTERONE ACETATE, NORETHINDRONE, NORGESTIMATE & ETHINYL ESTRADIOL 68:32 Progestogens and Oral Contraceptives

MEDROXYPROGESTERONE ACETATE

· 10 products · Temporary benefit (2), General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (3), General benefit (4), Listed, not a benefit (1) · strengths: 150mg/mL, 2.5mg, 5mg, 10mg, 100mg · Inj Sol-1mL Pref Syr, Tab

NORETHINDRONE

· 3 products · Listed, not a benefit (1), General benefit (2) · strengths: 0.35mg · Tab-28 Pk

DESOGESTREL & ETHINYL ESTRADIOL

· 12 products · General benefit · strengths: 0.15mg & 0.03mg, 3 Phase · Tab-21 Pk, Tab-28 Pk, Tabs-21 Pk, Tabs-28 Pk

DROSPIRENONE & ETHINYL ESTRADIOL

· 9 products · General benefit · strengths: 3.0mg & 0.03mg, 3.0mg & 0.02mg · Tab-21 Pk, Tab-28 Pk

ETHINYL ESTRADIOL & LEVONORGESTREL

· 20 products · General benefit (18), Off-Formulary Interchangeable, not an ODB benefit (2) · strengths: 20mcg & 100mcg, 0.03mg & 0.15mg, 3 Phase · Tab-21 Pk, Tab-28 Pk, Tab-91 Pk

ETHINYL ESTRADIOL & NORETHINDRONE

· 6 products · General benefit · strengths: 0.035mg & 0.5mg, 0.035mg & 1mg, 3 Phase · Tab-21 Pk, Tab-28 Pk

ETHINYL ESTRADIOL & NORETHINDRONE ACETATE

· 4 products · General benefit · strengths: 0.02mg & 1mg, 0.03mg & 1.5mg · Tab-21 Pk, Tab-28 Pk

LEVONORGESTREL

· 4 products · General benefit · strengths: 1.5mg · Tab-1 Tab Pk

NORGESTIMATE & ETHINYL ESTRADIOL

· 10 products · Listed, not a benefit (4), General benefit (6) · strengths: 3 Phase · Tab-21 Pk, Tab-28 Pk

DIENOGEST

· 5 products · Limited Use, codes 432 · strengths: 2mg · Tab

CYPROTERONE ACETATE & ETHINYL ESTRADIOL

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 2mg & 0.035mg · Tab-21 Pk

PROGESTERONE

· 8 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 100mg · Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 68:32

Full class listing Related classes: 68:04 Corticosteroids, 68:08 Androgens, 68:12 Contraceptives, 68:16 Estrogens, 68:20 Anti-Diabetic Agents, 68:24 Parathyroid Agents, 68:28 Pituitary Agents, 68:36 Thyroids, 68:38 Anti-Thyroids Same formulary class, not same indication: class membership alone does not establish equivalent uses.

What the Health Canada label says it is for

1 INDICATIONS SLYND is indicated for conception control in adolescent and adult women. SLYND tablets contain progestin only and do not contain an estrogen agent. Progestin-only pills may be called POPs or the "mini-pill". 1.1 Pediatrics Pediatrics (12-17 years of age): Safety and efficacy of SLYND have been established in adolescents. Use of this product before menarche is not indicated. 1.2 Geriatrics Geriatrics (≥ 65 years of age): SLYND is not indicated for use in postmenopausal women. https://pdf.hres.ca/dpd_pm/00070342.PDF PM date: April 12, 2023 Source product: SLYND; DIN 02522802; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.